Research Paper Volume 14, Issue 13 pp 5571—5589
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Figure 14. Experimental verification. (A) Results of TIMP1, S100P, HMMR, F2RL1, KRT6A, and SLC2A1 mRNA expression in A549, H1299 and 16HBE by RT-PCR. (B) Results of F2RL1, KRT6A, and SLC2A1 protein expression in A549, H1299 and 16HBE by western blot. (C) Staurosporine could inhibit cell migration in A549 and H1299 cells. *p < 0.05, **p < 0.01, ***p < 0.001.